Therapeutics and Medicines Management, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Private bag X7, Durban, 4001, South Africa.
School of Clinical Medicine Research Laboratory, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Metab Brain Dis. 2019 Oct;34(5):1281-1298. doi: 10.1007/s11011-019-00437-w. Epub 2019 Jun 13.
The associations between thyroid auto-immunity and neuro-psychiatric disorders are well-documented. However, there exists limited literature specifically linking auto-immune thyroid disease (AITD) to bipolar disorder (BD). Thus, we investigated the likely association between Hashimoto's disease and BD through the extra-thyroidal localisation of thyroid-stimulating hormone receptor (TSH-R) and thyroglobulin (TG) in limbic regions of normal and bipolar human adult brain. Further, we hypothesised that changes in thyroid expression in bipolar limbic cortex may contribute to mood dysregulation associated with BD. Immuno-chemistry and in-situ PCR were used to localise TSH-R/TG within the amygdala, cingulate gyrus and frontal cortex of normal (n = 5) and bipolar (n = 5) brains. Reverse-transcriptase qPCR provided fold-change differences in TSH-R gene expression. The results demonstrated reduced thyroid protein expression in bipolar limbic regions; these novel results correlate with other neuro-imaging reports that describe reduced cortico-limbic tissue volumes and neuro-physiological activity during BD. We also demonstrated TG-like proteins exclusive to bipolar amygdala neurons, and which relates to previous neuro-imaging studies of amygdala hyperactivity and enhanced emotional sensitivity in BD. Indeed, reduced TSH-R/TG in limbic regions may predispose to, or bear relevance in the pathophysiology of mood dysregulation and symptoms of BD. Further, we attribute mood dysregulation in BD to limbic-derived TSH-R, which probably provides potential targets for thyroid auto-immune factors during Hashimoto's disease. Consequently, this may lead to inactivated and/or damaged neurons. The neuro-pathology of diminished neuronal functioning or neuronal atrophy suggests a novel neuro-degeneration mechanism in BD.
自身免疫性甲状腺疾病与神经精神障碍之间的关联已有充分的文献记载。然而,将自身免疫性甲状腺疾病(AITD)与双相情感障碍(BD)联系起来的文献有限。因此,我们通过检测正常和双相成人大脑边缘区域中促甲状腺激素受体(TSH-R)和甲状腺球蛋白(TG)的甲状腺外定位,研究了桥本氏病与 BD 之间可能的关联。此外,我们假设双相边缘皮质中甲状腺表达的变化可能导致与 BD 相关的情绪失调。免疫化学和原位 PCR 用于定位 TSH-R/TG 在正常(n=5)和双相(n=5)大脑的杏仁核、扣带回和前额皮质中。逆转录 qPCR 提供了 TSH-R 基因表达的倍数变化差异。结果表明,双相边缘区域的甲状腺蛋白表达减少;这些新结果与其他神经影像学报告一致,这些报告描述了 BD 期间皮质-边缘组织体积和神经生理活动减少。我们还证明了 TG 样蛋白仅存在于双相杏仁核神经元中,这与之前关于杏仁核过度活跃和 BD 中增强的情绪敏感性的神经影像学研究相关。事实上,边缘区域中 TSH-R/TG 的减少可能导致情绪失调,或与 BD 的病理生理学和症状相关。此外,我们将 BD 中的情绪失调归因于边缘起源的 TSH-R,这可能为桥本氏病期间的甲状腺自身免疫因素提供潜在靶点。因此,这可能导致神经元失活和/或损伤。神经元功能减退或神经元萎缩的神经病理学表明 BD 中存在一种新的神经退行性机制。